Back to Legal & General Group Plc Legal & General Group Plc

SMMTSMMT

Showing 8 of 18 quarters

Position history for Legal & General Group PlcLegal & General Group Plc's holdings in Summit Therapeutics Inc.

Yes. Legal & General Group holds 18,247 shares of SMMT (Summit Therapeutics), worth $265,859, as of its Q2 2026 13F filing. It reduced the position by 13,645 shares (-42.8%) from Q1 2026. Legal & General Group has held SMMT since Q2 2023, across 13 quarterly 13F filings.

Current Value

$265,859

Current Shares

18,247

Total Value Change

+$53,110

Total Shares Change

+8,528

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
18,247
-42.8%
$265,8590.0%$14.57
0
2026-Q1
Increased
31,892
+16.6%
$604,6730.0%$18.96
28
2025-Q4
Increased
27,359
+3.1%
$478,5090.0%$17.49
25
2025-Q3
Increased
26,536
+0.6%
$548,2340.0%$20.66
24
2025-Q2
Increased
26,367
+33.8%
$561,0900.0%$21.28
31
2025-Q1
Increased
19,705
+95.9%
$380,1090.0%$19.29
38
2024-Q4
Increased
10,061
+3.5%
$179,5380.0%$17.85
16
2024-Q3
Decreased
9,719
-48.7%
$212,7490.0%$20.89
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used